NCT00574418

Far Infrared Radiation Treatment for Uterine Fibroids

Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Uterine Fibroids

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 2 (actual)
• Sponsor: GAAD Medical Research Institute Inc. · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A preliminary study to determine the efficacy of using energy specific far infrared (FIR) radiation for the treatment of uterine fibroids.

Detailed description

Uterine fibroids are the most common neoplasms of the female pelvis. These benign tumors are generally oval in shape and often highly vascular. On MR imaging exams, uterine fibroids are easily identifiable. They occur in 20-25% of women of reproductive age and can cause a variety of problems generally described as either bleeding or mass effects from the fibroid. We are postulating that energy specific electromagnetic radiation of the uterus will shrink the benign tumors.

Conditions

• Leiomyoma

Interventions

Type	Name	Description
RADIATION	Far Infrared Radiation (5μm to 20μm wavelength)	Far Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 minutes during each session.

Timeline

• Start date: 2006-01-01
• Primary completion: 2008-03-01
• Completion: 2008-09-01
• First posted: 2007-12-17
• Last updated: 2009-01-05

Locations

1 site across 1 country: Canada